Published in J Exp Med on March 01, 1973
Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity. J Virol (1988) 6.76
Role of macrophages in natural resistance to virus infections. Microbiol Rev (1979) 2.15
Defense mechanisms against bovine herpesvirus: relationship of virus-host cell events to susceptibility to antibody-complement cell lysis. Infect Immun (1975) 1.98
Host defense mechanisms against infectious bovine rhinotracheitis virus: in vitro stimulation of sensitized lymphocytes by virus antigen. Infect Immun (1974) 1.69
Mechanism of injury of virus-infected cells by antiviral antibody and complement: participation of IgG, F(ab')2, and the alternative complement pathway. J Exp Med (1976) 1.57
Mediation of immunity to intracellular infection (Toxoplasma and Besnoitia) within somatic cells. Infect Immun (1978) 1.52
Cellular immunity to herpes simplex virus mediated by interferon. J Exp Med (1974) 1.52
Cell-mediated immunity to Herpes simplex in humans: lymphocyte cytotoxicity measured by 51-Cr release from infected cells. Infect Immun (1975) 1.43
Role of macrophages in hepatitis induced by Herpes simplex virus types 1 and 2 in mice. Infect Immun (1977) 1.35
Role of T lymphocytes in cellular immune responses during herpes simplex virus infection in humans. Proc Natl Acad Sci U S A (1978) 1.35
Mechanisms of recovery from Herpesvirus infections -a review. Can J Comp Med (1978) 1.34
Passive immunization in experimental Herpesvirus hominis infection of newborn mice. Infect Immun (1975) 1.31
Immune interferon production by lymphoid cells: role in the inhibition of herpesviruses. Infect Immun (1976) 1.29
Effect of treatment with BCG on the course of visceral leishmaniasis in BALB/c mice. Infect Immun (1977) 1.23
Human polyomavirus in pregnancy. A model for the study of defence mechanisms to virus reactivation. Clin Exp Immunol (1983) 1.20
Human antibody-dependent cell-mediated cytotoxicity against target cells infected with respiratory syncytial virus. Clin Exp Immunol (1977) 1.18
Relationship of antibody to outcome in neonatal herpes simplex virus infections. Infect Immun (1980) 1.12
Defense mechanisms against infectious bovine rhinotracheitis virus: inhibition of virus infection by murine macrophages. Infect Immun (1975) 1.10
Production of chemotactic factor and lymphotoxin by human leukocytes stimulated with Herpes simplex virus. Infect Immun (1974) 1.06
Effect of immunosuppression on the genetic resistance of A2G mice to neurovirulent influenza virus. Infect Immun (1975) 1.06
A possible role for polymorphonuclear leucocytes in the defence against recrudescent herpes simplex virus infection in man. Immunology (1978) 1.01
Peripheral infection in culture of rat sensory neurons by herpes simplex virus. Infect Immun (1980) 0.98
Cell-mediated immunity to varicella-zoster virus measured by virus inactivation: mechanism and blocking of the reaction by specific antibody. Infect Immun (1979) 0.98
Characterization of a type-common human recombinant monoclonal antibody to herpes simplex virus with high therapeutic potential. J Clin Microbiol (1998) 0.98
Meningeal exudate cells in vaccinia meningitis of mice: role of local T cells. Infect Immun (1978) 0.91
Analysis of the inhibitory effect of peritoneal macrophages on the spread of herpes simplex virus. Infect Immun (1980) 0.90
Interactions between calf alveolar macrophages and parainfluenza-3 virus. Infect Immun (1977) 0.89
Cell cytotoxicity due to specific influenza antibody production in vitro after recent influenza antigen stimulation. Proc Natl Acad Sci U S A (1979) 0.83
Lysis of herpes simplex virus-infected cells early in the infectious cycle by human antiviral antibody and complement. Infect Immun (1981) 0.82
Scanning and transmission electron microscopic studies of complement-mediated lysis and antibody-dependent cell-mediated cytolysis of herpes simplex virus-infected human fibroblasts. Am J Pathol (1980) 0.79
Interactions of T-and B-lymphocytes and macrophages in recovery from virus infections. Proc R Soc Med (1973) 0.79
Analysis of ovine lentivirus infectivity and replication by using a focal immunoassay and an antigen-capture enzyme-linked immunosorbent assay. J Clin Microbiol (1992) 0.79
Role of antiviral antibodies in resistance against coxsackievirus B3 infection: interaction between preexisting antibodies and an interferon inducer. Infect Immun (1982) 0.78
In vitro studies on the mechanism of herpesvirus plaque growth inhibition by sensitized lymphocytes. Infect Immun (1977) 0.78
Immune stimulation, inflammation, and changes in hematopoiesis. Host responses of the murine spleen to infection with cytomegalovirus. Am J Pathol (1981) 0.76
Effect of staphylococcal protein A on complement-potentiated neutralization of herpes simplex virus and immune lysis of virus-infected cells. Infect Immun (1975) 0.75
Cytotoxic effects of lymphoid cells in vitro. Adv Immunol (1969) 8.18
Mechanism of immunologically specific killing of tumour cells by macrophages. Nature (1972) 4.63
Immune specific induction of interferon production in cultures of human blood lymphocytes. Science (1969) 4.43
Macrophages and age-dependent resistance to Herpes simplex virus in mice. J Immunol (1970) 4.15
Selective effects of anti-macrophage serum, silica and anti-lymphocyte serum on pathogenesis of herpes virus infection of young adult mice. J Immunol (1970) 3.49
N.A.S. symposium: new evidence as the basis for increased efforts in cancer research. Proc Natl Acad Sci U S A (1972) 3.28
Mechanisms of recovery from a generalized viral infection: mousepox. 3. Regression infectious foci. J Exp Med (1971) 3.07
Heterogeneity in the properties of 7 S and 19S rabbit-neutralizing antibodies to herpes simplex virus. J Immunol (1968) 2.90
Restriction of herpes simplex virus by macrophages. An analysis of the cell-virus interaction. J Exp Med (1971) 2.61
Microepidemiology of poliomyelitis and herpes-B infections: spread of the viruses within tissue cultures. J Immunol (1955) 2.59
Cell-mediated immunity in Herpesvirus hominis infections. Br Med J (1972) 2.54
Inhibition or enhancement of immunological injury of virus-infected cells. Proc Natl Acad Sci U S A (1971) 2.45
In vitro stimulation of sensitized lymphocytes by herpes simplex virus and vaccinia virus. Proc Natl Acad Sci U S A (1972) 2.29
Tissue injury in lymphocytic choriomeningitis viral infection: virus-induced immunologically specific release of a cytotoxic factor from immune lymphoid cells. Virology (1970) 2.00
Interaction between antigenically different cells. Virus-induced cytotoxicity by immune lymphoid cells in vitro. Acta Pathol Microbiol Scand (1969) 1.58
An in vitro measure of cellular immunity to fibroma virus. J Immunol (1970) 1.58
LEUKOCYTES AND INTERFERON IN THE HOST RESPONSE TO VIRAL INFECTIONS. I. MOUSE LEUKOCYTES AND LEUKOCYTE-PRODUCED INTERFERON IN VACCINIA VIRUS INFECTION IN VITRO. J Exp Med (1965) 1.46
An immuno-cytopathogenic interaction between sensitized leukocytes and epithelial cells carrying a persistent noncytocidal myxovirus infection. J Immunol (1968) 1.46
Further studies of variants of herpes simplex virus that produce syncytia or pocklike lesions in cell cultures. Am J Hyg (1961) 1.40
Transfer of interferon-producing macrophages: new approach to viral chemotherapy. Science (1970) 1.27
Iodine-125-labeled antibody to viral antigens: binding to the surface of virus-infected cells. Science (1972) 1.20
Infectious virus-antibody complexes: interaction with anti-immunoglobulins, complement, and rheumatoid factor. J Exp Med (1971) 1.13
Cell-to-cell transmission of herpes simplex virus in primary human amnion cells. Proc Soc Exp Biol Med (1971) 1.09
Inflammation and viral infection: chemotactic activity resulting from the interaction of antiviral antibody and complement with cells infected with herpes simplex virus. J Infect Dis (1972) 1.07
Cellular immunity. Ann Inst Pasteur (Paris) (1971) 1.06
Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics (1989) 19.10
Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci U S A (1989) 18.26
Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med (1979) 5.58
Effect of virus infections on the function of the immune system. Annu Rev Microbiol (1970) 4.30
An SV40-immortalized human corneal epithelial cell line and its characterization. Invest Ophthalmol Vis Sci (1995) 4.19
Behçet disease (Behçet syndrome). Semin Arthritis Rheum (1979) 3.88
Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene (1990) 3.65
Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype. Nature (1985) 3.62
Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med (1979) 3.62
CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire. Immunol Today (1989) 2.96
Thymus dependence of viral antigens. Nature (1975) 2.95
Heterogeneity in the properties of 7 S and 19S rabbit-neutralizing antibodies to herpes simplex virus. J Immunol (1968) 2.90
Continued expression of a poly(A)+ transcript of herpes simplex virus type 1 in trigeminal ganglia of latently infected mice. J Virol (1987) 2.78
Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1+ B-cell subset. Science (1987) 2.75
Latent ganglionic infection with herpes simplex virus types 1 and 2: viral reactivation in vivo after neurectomy. Science (1974) 2.71
Infectious virus-antibody complex in the blood of chronically infected mice. J Exp Med (1966) 2.68
Probing the human B-cell repertoire with EBV: polyreactive antibodies and CD5+ B lymphocytes. Annu Rev Immunol (1989) 2.63
C-myc transcript is induced in rat liver at a very early stage of regeneration or by cycloheximide treatment. Nature (1984) 2.63
Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes. Proc Natl Acad Sci U S A (1992) 2.48
Human CD4+ cells transfected with IL-16 cDNA are resistant to HIV-1 infection: inhibition of mRNA expression. Nat Med (1997) 2.47
Inhibition or enhancement of immunological injury of virus-infected cells. Proc Natl Acad Sci U S A (1971) 2.45
Brachial-ankle pulse wave velocity: an index of central arterial stiffness? J Hum Hypertens (2005) 2.36
Vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D prevents latent herpes in mice. Science (1985) 2.34
In vitro stimulation of sensitized lymphocytes by herpes simplex virus and vaccinia virus. Proc Natl Acad Sci U S A (1972) 2.29
ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy. J Clin Oncol (1998) 2.26
Cyclin-dependent kinase 2 (Cdk2) is required for centrosome duplication in mammalian cells. Curr Biol (1999) 2.25
Immune mechanisms by which the spread of viral infections is stopped. Cell Immunol (1974) 2.23
Comparison of direct and indirect solid-phase microradioimmunoassays for the detection of viral antigens and antiviral antibody. Appl Microbiol (1973) 2.23
Epithelial collagens and glycosaminoglycans in the embryonic cornea. Macromolecular order and morphogenesis in the basement membrane. J Cell Biol (1974) 2.18
HIV-associated nephropathy in transgenic mice expressing HIV-1 genes. Virology (1991) 2.16
A rapid determination of sodium dodecyl sulfate with methylene blue. Anal Biochem (1975) 2.15
Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol (1994) 2.13
Immunocytochemistry of cell surface heparan sulfate proteoglycan in mouse tissues. A light and electron microscopic study. J Histochem Cytochem (1987) 2.07
Virus-induced diabetes mellitus. XVIII. Inhibition by a nondiabetogenic variant of encephalomyocarditis virus. J Exp Med (1980) 2.07
Human diploid-cell rabies vaccine: efficacy of four doses. Lancet (1996) 2.07
Herpes simplex virus DNA and mRNA sequences in acutely and chronically infected trigeminal ganglia of mice. Virology (1978) 1.99
Scratching behavior induced by pruritogenic but not algesiogenic agents in mice. Eur J Pharmacol (1995) 1.98
Joining of the c-myc gene and a line 1 family member on chromosome 8 in a human primary giant cell carcinoma of the lung. Cancer Res (1990) 1.97
IA-1, a new marker for neuroendocrine differentiation in human lung cancer cell lines. Cancer Res (1993) 1.96
Latent infection of sensory ganglia with herpes simplex virus: efficacy of immunization. Science (1975) 1.95
Immunological response restricts number of cells in sensory ganglia infected with herpes simplex virus. Nature (1976) 1.95
Tendon collagen fibrillogenesis: intracellular subassemblies and cell surface changes associated with fibril growth. Dev Biol (1979) 1.95
Herpes simplex virus DNA sequences in the CNS of latently infected mice. Nature (1980) 1.95
Molecular mimicry: frequency of reactivity of monoclonal antiviral antibodies with normal tissues. J Virol (1986) 1.95
Antibodies to IA-2 and GAD65 in type 1 and type 2 diabetes: isotype restriction and polyclonality. Diabetes Care (2000) 1.91
Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res (1991) 1.89
Nucleotide sequences of eight human natural autoantibody VH regions reveals apparent restricted use of VH families. J Immunol (1989) 1.88
Lobar atelectasis: diagnostic pitfalls on chest radiography. Br J Radiol (2001) 1.84
Neutralization of an infectious herpes simplex virus-antibody complex by anti-gamma-globulin. Proc Natl Acad Sci U S A (1966) 1.84
Immunization with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: long-term protection and effect of revaccination. J Virol (1988) 1.81
Complications associated with transcatheter arterial embolization for hepatic tumors. Radiographics (1998) 1.79
Rapid micro-radioimmunoassay for the measurement of antiviral antibody. J Immunol (1972) 1.79
Virus-induced autoimmunity: monoclonal antibodies that react with endocrine tissues. Science (1983) 1.78
Latent infection of the peripheral ANS with herpes simplex virus. Nature (1975) 1.76
[Establishment of a new human endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen and progesterone receptors]. Nihon Sanka Fujinka Gakkai Zasshi (1985) 1.74
Human monoclonal autoantibodies that react with multiple endocrine organs. N Engl J Med (1983) 1.73
Enhancement of IgE-mediated histamine release from human basophils by viruses: role of interferon. J Exp Med (1977) 1.73
Multiple interferons in the circulation of patients with systemic lupus erythematosus and vasculitis. Arthritis Rheum (1982) 1.73
Virus-induced diabetes mellitus. XX. Polyendocrinopathy and autoimmunity. J Exp Med (1981) 1.72
Esophageal squamous cell carcinoma: pathology and prognosis. World J Surg (1994) 1.72
Elevated gamma-globulin and increased antibody production in mice infected with lactic dehydrogenase virus. J Exp Med (1966) 1.71
IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A (1996) 1.71
Acute and latent infection of sensory ganglia with herpes simplex virus: immune control and virus reactivation. J Gen Virol (1979) 1.71
Lymphocytes capable of making monoclonal autoantibodies that react with multiple organs are a common feature of the normal B cell repertoire. J Immunol (1984) 1.69
Virus-induced diabetes mellitus. I. Hyperglycemia and hypoinsulinemia in mice infected with encephalomyocarditis virus. J Exp Med (1973) 1.68
Homology between murine and human cellular DNA sequences and the terminal repetition of the S component of herpes simplex virus type 1 DNA. Cell (1982) 1.67
Theoretical study of the effects of vascular smooth muscle contraction on strain and stress distributions in arteries. Ann Biomed Eng (1999) 1.66
Clonal analysis of a human antibody response. II. Sequences of the VH genes of human IgM, IgG, and IgA to rabies virus reveal preferential utilization of VHIII segments and somatic hypermutation. J Immunol (1993) 1.65
Penetrating atherosclerotic ulcer of the aorta: imaging features and disease concept. Radiographics (2000) 1.64
CT diagnosis of catheter-induced septic thrombus of vena cava. J Comput Assist Tomogr (1990) 1.64
Multiple organ-reactive monoclonal autoantibodies. Nature (1983) 1.64
Neutralization of sensitized virus by purified components of complement. Proc Natl Acad Sci U S A (1970) 1.63
Monoreactive high affinity and polyreactive low affinity rheumatoid factors are produced by CD5+ B cells from patients with rheumatoid arthritis. J Exp Med (1988) 1.62
Comparative study of abortive and nonabortive rabies in mice. J Infect Dis (1969) 1.62
Biomechanical study of full-contact karate contrasted with boxing. J Neurosurg (1986) 1.61
Adult-onset Krabbe disease with homozygous T1853C mutation in the galactocerebrosidase gene. Unusual MRI findings of corticospinal tract demyelination. Neurology (1997) 1.61
Prevention of ultraviolet-light-induced herpes labialis by sunscreen. Lancet (1991) 1.60
Aberrations of the p53 tumor suppressor gene in human non-small cell carcinomas of the lung. Cancer Res (1992) 1.60
Exophytic spread of hepatobiliary disease via perihepatic ligaments: demonstration with CT and US. Radiology (1989) 1.60
Retinal complications during interferon therapy for chronic hepatitis C. Am J Gastroenterol (1996) 1.60
Cytotoxic autoantibodies to beta cells in the serum of patients with insulin-dependent diabetes mellitus. N Engl J Med (1980) 1.59
F-SSCP: fluorescence-based polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP) analysis. PCR Methods Appl (1992) 1.58
A cloning vehicle suitable for strand separation. Gene (1980) 1.57
Immunologic dynamics in hemophiliac patients infected with hepatitis C virus and human immunodeficiency virus: influence of antiretroviral therapy. Blood (2000) 1.56
Stiffness and elastic behavior of human intracranial and extracranial arteries. J Biomech (1980) 1.56
Targeted therapy of spinal cord glioma with a genetically modified Salmonella typhimurium. Cell Prolif (2009) 1.55
Hypermethylation in the retinoblastoma gene is associated with unilateral, sporadic retinoblastoma. Cancer Genet Cytogenet (1997) 1.55
Cerebral hypoperfusion and hypometabolism with altered striatal signal intensity in chorea-acanthocytosis: a combined PET and MRI study. Mov Disord (1998) 1.54
Cellular immunity to herpes simplex virus mediated by interferon. J Exp Med (1974) 1.52
Organization of sequences related to U6 RNA in the human genome. Nucleic Acids Res (1981) 1.52
Specific detection of positive and negative stranded hepatitis C viral RNA using chemical RNA modification. Arch Virol (1994) 1.52
Anterior capsule contraction and intraocular lens dislocation in eyes with pseudoexfoliation syndrome. Br J Ophthalmol (1998) 1.52
Virus-induced diabetes mellitus. XV. Beta cell damage and insulin-dependent hyperglycemia in mice infected with coxsackie virus B4. J Exp Med (1978) 1.52
Thermotropic phase behavior and stability of monosialoganglioside micelles in aqueous solution. Biophys J (1996) 1.52
Expressional regulation of smooth muscle cell-specific genes in association with phenotypic modulation. Mol Cell Biochem (1999) 1.51